Supportive evidence for the association between the Gln2Pro polymorphism in the SIGMAR1 gene and schizophrenia in the Japanese population: a case-control study and an updated meta-analysis

scientific article published on 19 July 2012

Supportive evidence for the association between the Gln2Pro polymorphism in the SIGMAR1 gene and schizophrenia in the Japanese population: a case-control study and an updated meta-analysis is …
instance of (P31):
scholarly articleQ13442814
meta-analysisQ815382

External links are
P356DOI10.1016/J.SCHRES.2012.06.043
P698PubMed publication ID22818711

P2093author name stringYuichiro Watanabe
Toshiyuki Someya
Jun Egawa
Ayako Nunokawa
Masako Shibuya
Naoshi Kaneko
P433issue2-3
P921main subjectschizophreniaQ41112
P304page(s)279-280
P577publication date2012-07-19
P1433published inSchizophrenia ResearchQ7431607
P1476titleSupportive evidence for the association between the Gln2Pro polymorphism in the SIGMAR1 gene and schizophrenia in the Japanese population: a case-control study and an updated meta-analysis
P478volume141

Reverse relations

cites work (P2860)
Q42317501Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction
Q41572995Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine
Q38262682The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: implications in neurological disorders
Q51750311The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases.
Q48608696Why sigma-1 receptor dysfunction might confer vulnerability to cannabis-induced psychosis

Search more.